Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
90
NCT03261739
Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 28, 2017
Completion: Aug 24, 2018
NCT02795299
Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis
Phase: Phase 2
Start: Jan 31, 2018
Completion: Sep 30, 2019
NCT03900325
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis
Start: Aug 1, 2019
Completion: Apr 30, 2020